All In Biotech

Drug Trial Radar · NCT02463357

Three New Ideas to Protect Special Forces From the Stress of High Altitude

Last checked: Nov 19, 2026Latest source record: Mar 30, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

148

Actual

Start

Aug 2015

Primary completion

Sep 2016

Study completion Sep 2016

Sponsor

Lead sponsor
University of Colorado, DenverAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Alma College
First posted
Jun 4, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Factorial
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
Male only, from 18 years, up to 30 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Acute Mountain Sickness (AMS) is a well-documented syndrome that affects 42% of non-acclimatized individuals traveling to altitudes above 10,000 feet. Decreased barometric pressure, which leads to low blood oxygen levels, is the primary casual factor of AMS. Symptoms of AMS are characterized by headache, nausea, vomiting, dizziness, fatigue and difficultly sleeping. Moreover, when people travel to high altitude, cognitive performance and endurance exercise capacity are impaired. Therefore, the goal of this research is to identify effective pharmacological agents that will help reduce the symptoms of AMS and improve physical and cognitive performance at high altitude. The investigators will study the efficacy of the dietary supplement, quercetin, the drugs nifedipine (extended release) and methazolamide taken together, the drug metformin, and the drug nitrite in reducing symptoms of AMS and improving cognitive and exercise performance at high altitudes.

Conditions

  • Mountain Sickness

Interventions

  • QuercetinDietary supplement

  • Nifedipine extended releaseDrug

  • MethazolamideDrug

  • MetforminDrug

  • PlaceboDrug

  • NitriteDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Environmental Symptoms Questionnaire at High AltitudeTime frame: Baseline and during high altitude exposure (3 days, AM/PM)
  2. Change in Lake Louise AMS Scoring System at High AltitudeTime frame: Baseline and during high altitude exposure (3 days, AM/PM)
  3. Change in Army Physical Fitness Test (APFT) at High AltitudeTime frame: Baseline, 1st day at high altitude
  4. Change in Uphill Hike at High AltitudeTime frame: 2nd day at altitude
  5. Change in Defense Automated Neurobehavioral Assessment (DANA) Reaction Time at High AltitudeTime frame: Baseline and and 1st day at high altitude

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Alma College

    Alma, Michigan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.